Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127510211 | 12751021 | 1 | I | 20090714 | 20091104 | 20160915 | 20160915 | EXP | PHHO2009US13678 | NOVARTIS | 56.08 | YR | F | Y | 113.40000 | KG | 20160915 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127510211 | 12751021 | 1 | PS | LOTREL | AMLODIPINE BESYLATEBENAZEPRIL HYDROCHLORIDE | 1 | Oral | UNK | 20364 | ||||||||||
| 127510211 | 12751021 | 2 | SS | CELECOXIB. | CELECOXIB | 1 | Oral | 200 MG, UNK | Y | 0 | 200 | MG | |||||||
| 127510211 | 12751021 | 3 | SS | IBUPROFEN. | IBUPROFEN | 1 | Oral | 200 MG, UNK | Y | 0 | 200 | MG | |||||||
| 127510211 | 12751021 | 4 | SS | NAPROXEN. | NAPROXEN | 1 | Oral | 200 MG, UNK | Y | 0 | 200 | MG | TABLET | ||||||
| 127510211 | 12751021 | 5 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Unknown | UNK | Y | 0 | |||||||||
| 127510211 | 12751021 | 6 | C | KLOR-CON | POTASSIUM CHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 127510211 | 12751021 | 7 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 0 | |||||||||||
| 127510211 | 12751021 | 8 | C | DIAZEPAM. | DIAZEPAM | 1 | Oral | U | 0 | ||||||||||
| 127510211 | 12751021 | 9 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | U | 0 | ||||||||||
| 127510211 | 12751021 | 10 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | Oral | U | 0 | ||||||||||
| 127510211 | 12751021 | 11 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
| 127510211 | 12751021 | 12 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | U | 0 | ||||||||||
| 127510211 | 12751021 | 13 | C | ALBUTEROL. | ALBUTEROL | 1 | Respiratory (inhalation) | U | 0 | ||||||||||
| 127510211 | 12751021 | 14 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Oral | U | 0 | ||||||||||
| 127510211 | 12751021 | 15 | C | PAROXETINE HYDROCHLORIDE. | PAROXETINE HYDROCHLORIDE | 1 | Oral | U | 0 | ||||||||||
| 127510211 | 12751021 | 16 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | UNK MG, UNK | U | 0 | |||||||||
| 127510211 | 12751021 | 17 | C | GAS-X | DIMETHICONE | 1 | Oral | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127510211 | 12751021 | 1 | Hypertension |
| 127510211 | 12751021 | 2 | Arthritis |
| 127510211 | 12751021 | 3 | Arthritis |
| 127510211 | 12751021 | 4 | Arthritis |
| 127510211 | 12751021 | 5 | Product used for unknown indication |
| 127510211 | 12751021 | 6 | Product used for unknown indication |
| 127510211 | 12751021 | 7 | Product used for unknown indication |
| 127510211 | 12751021 | 8 | Product used for unknown indication |
| 127510211 | 12751021 | 9 | Product used for unknown indication |
| 127510211 | 12751021 | 10 | Product used for unknown indication |
| 127510211 | 12751021 | 11 | Product used for unknown indication |
| 127510211 | 12751021 | 12 | Product used for unknown indication |
| 127510211 | 12751021 | 13 | Product used for unknown indication |
| 127510211 | 12751021 | 14 | Product used for unknown indication |
| 127510211 | 12751021 | 15 | Product used for unknown indication |
| 127510211 | 12751021 | 16 | Product used for unknown indication |
| 127510211 | 12751021 | 17 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127510211 | 12751021 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127510211 | 12751021 | Dysphagia | |
| 127510211 | 12751021 | Face oedema | |
| 127510211 | 12751021 | Hypersensitivity | |
| 127510211 | 12751021 | Hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127510211 | 12751021 | 1 | 2007 | 20090715 | 0 | |
| 127510211 | 12751021 | 2 | 20090111 | 20120801 | 0 | |
| 127510211 | 12751021 | 3 | 20090111 | 20120801 | 0 | |
| 127510211 | 12751021 | 4 | 20090111 | 20120801 | 0 | |
| 127510211 | 12751021 | 5 | 20090110 | 20090714 | 0 | |
| 127510211 | 12751021 | 6 | 20090310 | 0 | ||
| 127510211 | 12751021 | 7 | 200903 | 0 | ||
| 127510211 | 12751021 | 8 | 2000 | 0 | ||
| 127510211 | 12751021 | 9 | 2007 | 0 | ||
| 127510211 | 12751021 | 10 | 1995 | 0 | ||
| 127510211 | 12751021 | 11 | 2008 | 0 | ||
| 127510211 | 12751021 | 12 | 2003 | 0 | ||
| 127510211 | 12751021 | 13 | 1992 | 0 | ||
| 127510211 | 12751021 | 14 | 2000 | 0 | ||
| 127510211 | 12751021 | 15 | 20090310 | 0 | ||
| 127510211 | 12751021 | 16 | 20090429 | 0 | ||
| 127510211 | 12751021 | 17 | 20090202 | 0 |